跳至主要内容
临床试验/ACTRN12613000315718
ACTRN12613000315718已完成不适用

Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house dust mites: A Double-Blind-Placebo-Controlled Randomised Trial

Marmara University medical faculty0 个研究点目标入组 60 人开始时间: 2013年3月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
5 Years 至 10 Years(—)
性别
All

入选标准

  • Children aged between 5-10 years of both genders with the history of persistent allergic rhinitis without asthmatic symptoms.

排除标准

  • Allergic asthma, previous allergen immunotherapy, chronic disease, malignancy.

研究者

发起方
Marmara University medical faculty

相似试验

招募中
不适用
Efficacy of sublingual allergen immunotherapy in asthma with allergic rhinitisAsthma with allergic rhinitis
JPRN-UMIN000022390Atami Hospital, International University of Health and Welfare100
进行中(未招募)
不适用
Study on the effectiveness of allergen immunotherapy in patients with house dust mite-induced allergic rhinitis and other associated allergic conditions
ISRCTN32263767Hong Kong Sanatorium & Hospital120
进行中(未招募)
不适用
A study, which aims to evaluate the efficacy and safety of LAIS® Birch-Alder tablets in patients suffering from allergic inflammation of the conjunctiva and rhinitis caused by birch pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 17.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853
EUCTR2013-002129-43-DEofarma S.p.A.
进行中(未招募)
1 期
Efficacy and Safety of sublingual immunotherapy with Allergoid LAIS Birch tablets for patients with tree pollen-induced allergic rhinoconjunctivitis with or without mild controlled asthma
EUCTR2018-002596-18-ITOFARMA S.P.A.110
进行中(未招募)
1 期
A study which aims at evaluating the efficacy and safety of LAIS® Grass tablets in patients suffering from g from allergic inflammation of the conjunctiva and rhinitis which are caused by grass pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 16.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853
EUCTR2012-004916-79-DEofarma S.p.A.200
Effects of dust mite sublingual immunotherapy in... | 临床试验